Credit Suisse AG boosted its position in Henry Schein, Inc. (NASDAQ:HSIC) by 3.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 167,003 shares of the company’s stock after buying an additional 4,810 shares during the period. Credit Suisse AG owned approximately 0.21% of Henry Schein worth $28,386,000 at the end of the most recent quarter.
Other hedge funds have also recently bought and sold shares of the company. Chevy Chase Trust Holdings Inc. raised its position in shares of Henry Schein by 1.4% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 269,458 shares of the company’s stock worth $45,800,000 after buying an additional 3,699 shares during the period. Macquarie Group Ltd. increased its position in Henry Schein by 84.0% in the fourth quarter. Macquarie Group Ltd. now owns 4,600 shares of the company’s stock worth $698,000 after buying an additional 2,100 shares in the last quarter. Kentucky Retirement Systems Insurance Trust Fund acquired a new position in Henry Schein during the fourth quarter worth about $395,000. Kentucky Retirement Systems acquired a new position in Henry Schein during the fourth quarter worth about $886,000. Finally, Quadrature Capital Ltd acquired a new position in Henry Schein during the fourth quarter worth about $1,140,000. 90.62% of the stock is currently owned by institutional investors.
Shares of Henry Schein, Inc. (NASDAQ:HSIC) traded up 0.04% on Friday, hitting $182.91. 319,018 shares of the company traded hands. The company has a market capitalization of $14.51 billion, a PE ratio of 27.80 and a beta of 1.09. Henry Schein, Inc. has a 12 month low of $146.23 and a 12 month high of $186.99. The stock’s 50-day moving average price is $183.62 and its 200-day moving average price is $173.89.
Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, May 9th. The company reported $1.76 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.65 by $0.11. The firm had revenue of $2.92 billion during the quarter, compared to analysts’ expectations of $2.83 billion. Henry Schein had a net margin of 4.53% and a return on equity of 19.74%. Henry Schein’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.41 EPS. On average, equities analysts predict that Henry Schein, Inc. will post $7.28 earnings per share for the current year.
ILLEGAL ACTIVITY WARNING: “Henry Schein, Inc. (HSIC) Stake Increased by Credit Suisse AG” was originally posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this story on another domain, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The legal version of this story can be accessed at https://www.chaffeybreeze.com/2017/07/28/henry-schein-inc-hsic-stake-increased-by-credit-suisse-ag-updated-updated-updated.html.
HSIC has been the topic of a number of recent research reports. Zacks Investment Research downgraded shares of Henry Schein from a “buy” rating to a “hold” rating in a research note on Friday, June 23rd. Jefferies Group LLC restated a “hold” rating and issued a $177.00 target price on shares of Henry Schein in a research note on Friday, July 21st. Piper Jaffray Companies started coverage on shares of Henry Schein in a research note on Monday, June 12th. They issued a “neutral” rating and a $200.00 target price for the company. Stifel Nicolaus restated a “hold” rating on shares of Henry Schein in a research note on Thursday, July 6th. Finally, Craig Hallum started coverage on shares of Henry Schein in a research note on Tuesday, April 11th. They issued a “hold” rating for the company. Eleven equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Henry Schein presently has a consensus rating of “Hold” and a consensus target price of $183.40.
In related news, EVP Gerald A. Benjamin sold 12,578 shares of the stock in a transaction on Thursday, May 11th. The shares were sold at an average price of $175.10, for a total transaction of $2,202,407.80. Following the completion of the sale, the executive vice president now owns 44,061 shares in the company, valued at approximately $7,715,081.10. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 1.27% of the stock is owned by corporate insiders.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.